Advanced Filters
noise
Found 65,447 clinical trials
V Vanessa Jewell, PhD

REAL-Fam Feasibility Study for Youth Diabetes Management

The goal of this clinical trial is to learn if the REAL-Fam occupational therapy intervention is feasible to study in a larger-scale randomized controlled trial. It will also seek to understand how the intervention influences how a rural family participates in and manages their child's type 1 diabetes, their family …

2 - 99 years of age All Phase N/A
A Ali Bin Asim, MS-OMPT

Effect of Muscle Energy Technique on Latissimus Dorsi on Pain , Functional Disability and Range of Motion in Patients With Mechanical Low Back Pain

Mechanical low back pain (LBP) stems from spinal structures or surrounding tissues, often caused by overuse or trauma, and is prevalent globally with high recurrence rates. Key contributing factors include biomechanical, psychological, and social elements. The latissimus dorsi (LD), along with other back muscles, plays a crucial role in lumbar …

30 - 55 years of age All Phase N/A
H Hossam A Hassan, MD

Micropulse Laser in Treatment of Initial and Refractory Cases of Center-Involved Diabetic Macular Edema

This study aims to evaluate the effect of subthreshold 577 nm micropulse laser photocoagulation in the treatment of initial and refractory cases of Center-Involved Diabetic Macular Edema.

18 years of age All Phase N/A
J Jun Jiang

Prognostic Values of Coronary Microvascular Dysfunction in Patients With Dilated Cardiomyopathy

The goal of this observational study is to learn about the long-term prognostic of coronary microvascular dysfuction in Patients with Dilated Cardiomyopathy. The main question it aims to answer is: Does the coronary microvascular dysfunction impact the outcomes in Patients with Dilated Cardiomyopathy.

18 years of age All Phase N/A
H Hannah Jordan

Improving Physical Ability and Cellular Senescence Elimination in HIV

This clinical trial is a Phase II study designed to test the safety and effectiveness of a combination of dasatinib and quercetin (D+Q) in improving physical function for people with HIV who are frail or prefrail. The study will involve 80 participants, all aged 50 or older, who have been …

50 years of age All Phase 2
N Noa Ben Aroya milshtein, MD

Stepped-Care for Suicidal Youth and Children

The goal of this RCT study is to test the efficacy of a stratified stepped-care (SSC) model in reducing suicidal thoughts and behaviors (STB) in children and adolescents. The main questions it aims to answer are: Does the SSC model effectively reduce STB and mental health symptoms? Can the SSC …

6 - 18 years of age All Phase N/A

Anatomical Assessment of Orbital Contents on Imaging (EACOI)

This is a single-center retrospective study based on existing data. The study focuses on the anatomical content of the orbit, and in particular the anatomy of the oculomotor muscles in the orbit, which are involved in eye movements. There are 6 of these muscles, with the superior, inferior, medial and …

18 years of age All Phase N/A
T Traci Bethea

Assessing the Feasibility of Web-based Insomnia Treatment Among Prostate Cancer Survivors

This pilot study will recruit Black/African American prostate cancer survivors into a clinical trial and will randomize each person to 1 of 2 possible treatments - an internet-based treatment for insomnia called Sleep Healthy Using the Internet (SHUTi) or an educational website. SHUTi provides the treatment - cognitive behavioral therapy …

21 years of age Male Phase N/A
T Tabatha Yent, LPN

Evaluating the Efficacy of OCM™ (Omeza® Complete Matrix) in the Treatment of Diabetic Foot Ulcers

This study aims to compare two treatment approaches for diabetic foot ulcers (DFUs): the standard of care (SOC) alone versus SOC combined with OCM. Researchers will evaluate whether adding OCM increases the likelihood of ulcers healing completely by the end of the trial period.

18 years of age All Phase N/A

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

This is a phase II study looking at patient response to treatment with the combination dinutuximab, temozolomide, irinotecan, and GM-CSF.

1 - 31 years of age All Phase 2

Simplify language using AI